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Abstract
The neonatal immune response is impaired during the first weeks after birth. To obtain a better
understanding of this immaturity, we investigated the development of T cell interactions with
B cells in mice. For this purpose, we analyzed the immune response to three T-dependent antigens
in vivo: (i) the polyclonal antibody response induced by vaccinia virus; (ii) the production of
polyclonal and specific antibodies following immunization with hapten–carrier conjugates; (iii) the
mouse mammary tumor virus superantigen (sAg) response involving an increase in sAg-reactive
T cells and induction of polyclonal antibody production. After vaccinia virus injection into
neonates, the polyclonal antibody response was similar to that observed in adult mice. The
antibody response to hapten–carrier conjugates, however, was delayed and reduced. Injection with
sAg-expressing B cells from neonatal or adult mice allowed us to determine whether B cells,
T cells or both were implicated in the reduced immune response. In these sAg responses, neonatal
T cells were stimulated by both neonatal and adult sAg-presenting B cells but only B cells from
adult mice differentiated into IgM- and IgG-secreting plasma cells in the neonatal environment in
vivo. Injecting neonatal B cells into adult mice did not induce antibody production. These results
demonstrate that the environment of the neonatal lymph node is able to support a T and B cell
response, and that immaturity of B cells plays a key role in the reduced immune response
observed in the neonate.
Introduction
Shortly after birth, antibody responses to type 1 T-independent
antigens are high, whereas T-dependent antibody secretion
is often delayed and reduced (for review see 1,2). For most
T-dependent antigens, only weak antibody production has
been found until 2–8 weeks after birth (3–5). Immaturity of
B cells, T cells and macrophages as well as the presence of
maternal antibodies and reduced antigen trapping by
follicular dendritic cells have been implicated in this impaired
T-dependent immune response (2,6–9). Although T cells can
be primed shortly after birth (10–13), they have been shown
to secrete a limited panel of cytokines when compared to
adult mice (2,14). Priming of mice shortly after birth with
T-dependent antigens can result in strong Th1 or Th2
responses when re-challenged in vitro or in vivo later in
life (11,15).
To investigate the role of B and T cells in the reduced
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neonatal immune response we compared the in vivo antibody
production of mice at different ages within the first 10 days
after immunization. Three T-dependent antigens with different
immune-stimulation properties were used: (i) protein–hapten
complexes [NP-CGG (4-hydroxy-3-nitrophenyl) acetyl conjug-
ated to chicken gammaglobulin] (16), (ii) vaccinia virus (17)
and (iii) mouse mammary tumor virus (MMTV) superantigens
(sAg) (18).
It has been shown that injection of adult mice with NP-CGG
in alum (with or without addition of pertussis toxin) results in
a strong IgG response which becomes detectable 5–6 days
after immunization and further increases by day 10 (16).
Similarly, vaccinia virus induces a strong T–B cell collabora-
tion, and polyclonal B cell differentiation to IgG secretion
within 6 days of injection into adult mice. The specific anti-
vaccinia IgG response becomes detectable later (17). MMTV
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exists either as an endogenous provirus (e.g. Mtv-7) or as
infectious retrovirus particles (MMTV). Endogenous Mtv-7 and
infectious MMTV express sAg on the surface of B lymphocytes
(18–20), which stimulate T cells expressing one or several
TCR Vβ elements (18,21,22). Injection of adult mice with
Mtv-7-expressing B cells or infection with MMTV(SW) result
in a strong and rapid activation of sAg-specific T cells (23,24).
Thereafter, B cells receive sAg-mediated ‘cognate’ help from
activated T cells and differentiate into IgG-secreting plasma
cells within 5–6 days of virus injection (25,26). T cell priming
as well as extrafollicular and follicular B cell differentiation are
very similar to responses to classical antigens (16). For
MMTV(SW) and Mtv-7, the sAg-presenting cells are B cells
and the responding CD41 T cells express TCR Vβ6 (21,24,25).
Shortly after birth, the spleen contains only few mature B
and T cells, whereas neonatal lymph nodes have comparable
proportions of B and T cells to adult mice. Therefore, we
decided to analyze the immune response in peripheral lymph
nodes. Our study demonstrated that neonatal mice produced
IgG antibodies after vaccinia immunization at levels similar to
adult mice. Since responses to classical antigens were
reduced and delayed in neonatal mice, we used MMTV
sAg to show that (i) the lymph node architecture was not
responsible for the neonatal unresponsiveness; (ii) T cell
stimulation by either neonatal or adult B cells expressing
MMTV sAg was similar; (iii) antibody secretion was only
observed after injection of B cells derived from adult mice
and (iv) neonatal B cells did not differentiate into antibody-
secreting cells in an adult or neonatal environment. These
data suggest that unless additional factors are present,
neonatal B cells are unable to respond to or to induce
T cell help.
Methods
Mice
BALB/c mice were obtained from Harlan Olac (London, UK).
MMTV(SW)-infected BALB/c breeders were selected from
mice originally purchased from IFFA Credo (L’Arlabesque,
France). Mtv-7 congenic BALB/c (BALB.D2) (27) were bred
at the Swiss Institute for Cancer Research (ISREC).
MMTV isolation
Milk was aspirated from lactating MMTV(SW)-infected BALB/c
mice after i.p. injection of 0.5 IU of oxytocin (Sandoz, Basel,
Switzerland) (24). Before storing as aliquots at –70°C, the
milk was diluted 1:3 in PBS, pH 7.4, centrifuged at 600 g for
10 min to skim and remove cells. The virus was titrated as
previously described and ~53107–108 virus particles were
injected per mouse (24).
Antigens and immunizations
NP (Cambridge Research Biochemicals, Northwich, UK) was
conjugated to CGG (Sigma, St Louis, MO). Mice of different
ages were injected either with 20 µg alum-precipitated (Sigma)
NP-CGG with or without 53108 Bordatella pertussis organisms
(Lederle, Gosport, UK) (these reagents were kindly provided
by I. C. M. MacLennan, Birmingham, UK), 106 p.f.u. of wild-
type vaccinia virus (kindly provided by F. Luthi, Lausanne,
Switzerland), 108 MMTV(SW) particles or 33105 lymph node
cells of Mtv-7-congenic BALB.D2 mice. Popliteal lymph nodes
of BALB.D2 mice were removed and mechanically dissociated
in sterile PBS. T cell-depleted lymph node cells were obtained
after incubation of total lymph node cells with anti-Thy-1
(AT83) (28), anti-CD4 (3.168.8.1) (29) and anti-CD8 (RL172-
4) (30) antibodies and rabbit complement (Saxon Europe,
Suffolk, UK). After washing and counting, cells were injected
into both hind footpads of neonatal mice. To ensure that the
transferred cells reached the neonatal lymph nodes, control
cells were labeled for 1 min with the aliphatic fluorescent
chromophore PKH26 (Sigma). At different time points after
injection into the neonates, transferred cells were visualized
on frozen sections obtained from the draining popliteal lymph
nodes using fluorescence microscopy.
Flow cytometry
Lymphocytes were labeled with the following antibodies:
FITC-conjugated anti-Vβ6 (44-22-1) (31) FITC-conjugated anti-
B220, phycoerythrin (PE)-conjugated anti-CD4 (GK1.5;
Becton Dickinson, Basel, Switzerland), PE-conjugated anti-
CD8 (Boehringer, Mannheim, Germany). The cells were ana-
lyzed on a FACScan (Becton Dickinson) after exclusion of
dead cells using forward and side scatter analysis.
ELISPOT assay
The numbers of Ig-secreting cells as well as Ig isotypes were
determined as previously described (32). Briefly, microtiter
plates (Maxisorp; Nunc, Oslo, Norway) were coated with goat
anti-mouse IgG and IgM (Tago, Burlingame, CA), and cells
isolated from lymph nodes were serially diluted from 105 cells/
well and incubated for 4 h at 37°C. The Ig-secreting cells
were then determined with biotinylated goat anti-mouse IgM,
IgG1, IgG2a, IgG2b and IgG3 (Caltag, San Francisco, CA).
After incubation with a streptavidin-conjugated alkaline phos-
phatase (Boehringer), the plates were developed with a
solution of 5-bromo-4-chloro-3-indolyl phosphate (Sigma). The
spots were counted under a dissection microscope.
ELISA
Flat-bottom 96-well microtiter plates were coated overnight at
4°C with 50 µl of either NP-BSA (5 µg/ml) or anti-murine IgG
1 IgM (2 µg/ml) (Tago). After washing with 0.05% Tween 20
in PBS, the plates were blocked with 1% BSA. Diluted test
sera were added after 1 h and incubated overnight at 4°C.
A high titer anti-NP immune serum of BALB/c mice or murine
IgG and IgM mAb were used as positive controls. Pre-immune
serum of BALB/c mice served as a negative control. Bound
antibodies were detected using biotinylated goat anti-murine
IgM (Caltag) or anti-murine IgG (Amersham Rahn, Zurich,
Switzerland) followed by streptavidin-conjugated alkaline
phosphatase (Boehringer). The adsorbance at 405 nm of
p-nitrophenyl phosphate (Sigma) filled wells was determined
with a Titertek Multiscan spectrophotometer.
Results
Induction of a polyclonal IgG response by vaccinia virus in
neonatal mice
Since vaccinia virus is a potent inducer of cytokines and of
T and B cell responses, we injected the virus into the hind
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Fig. 1. Antibody response to vaccinia virus and NP-CGG in neonatal and adult mice. Mice at the indicated ages were injected into the hind
footpad with either vaccinia virus or NP-CGG in Alum. When indicated NP-CGG was injected together with killed B. pertussis bacteria. Either
6 or 10 days later, the number of IgG-secreting cells in the popliteal draining lymph node was determined by ELISPOT (A and B). The specific
IgG response towards NP-CGG in serum is shown in (C; day 6) and (D; day 10) as determined by ELISA. Controls are non-injected littermates.
footpad of mice of different ages and studied the early
polyclonal B cell activation in the draining popliteal lymph
nodes. Mice aged 7–8, 17–20 and 29–32 days produced a
strong polyclonal B cell activation and polyclonal IgG secre-
tion within 6 days after injection of vaccinia virus as shown
by ELISPOT (see Fig. 1A). Ten days after injection, this
response decreased in all animals (see Fig. 1B). At these
early time points no vaccinia-virus specific antibodies were
detectable in the serum (data not shown). These results show
that neonatal mice are already able to produce a comparable
polyclonal T cell-dependent antibody response to that
observed in adult mice in the lymph node draining the site
of injection.
Development of the antibody response to hapten–protein
complexes
NP-CGG in alum, with or without the addition of killed B.
pertussis bacteria, was used to investigate a classical hapten
antigen response in neonatal mice. NP-specific IgG serum
levels were measured by ELISA at 6 and 10 days after
immunization (Fig. 1C and D). Six days after immunization,
no anti-NP antibody responses were detected in 8-day-old
mice. Although the response to NP-CGG became detectable
10 days after injection it was still 10-fold lower than that of
adult animals. In mice of all ages, at this later time point B.
pertussis increased the specific IgG responses. The numbers
of IgG-secreting B cells in the draining popliteal lymph nodes
were determined using an ELISPOT assay (Fig. 1A and B).
Six days after injection, very few Ig-secreting cells were found
in 8-day-old mice compared to high levels in adult mice.
However, 10 days after immunization, neonatal and adult
mice had intermediate levels of antibody-secreting cells.
Polyclonal activation followed similar kinetics to the specific
antibody response. These results show that neonatal mice are
capable of producing T cell-dependent antibody responses to
soluble antigens; however, the responses are weaker and
delayed when compared to adult mice. To address the
question whether reduced frequency of antigen-reactive
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Fig. 2. Kinetics of sAg-induced T cell activation. BALB/c mice were
injected into the footpad at different ages after birth with MMTV(SW)-
infected milk (d) or lymph node cells from adult BALB.D2 mice
(containing 0.93106 B cells) (s). Control uninjected mice are
represented by (u). T cell-depleted or total lymph node cells gave
similar results provided that the number of injected B cells was kept
constant. Six days after injection, the increase in Vβ61 CD41 T cells
was measured by FACS analysis. Each time point shows the age of
mice at the time of the injection and represents an experiment with
a pool of three to six mice. The kinetics were repeated 3–4 times in
separate experiments and similar results were obtained.
B cells or immaturity of the immune response were responsible
for this reduced and delayed response, we used MMTV sAg.
Development of the Mtv-7 sAg-induced neonatal peripheral
T cell response
To analyze the development of the sAg-mediated T cell
response, we injected BALB/c mice with lymph node cells
from Mtv-7-congenic mice. Lymph node cells (33106) from
adult or 10-day-old Mtv-7-congenic BALB.D2 mice were
injected into the footpad of recipient BALB/c mice of different
ages—ranging from 3 to 60 days. To ensure that cells
transferred to the neonatal or adult footpad reached the lymph
node efficiently, adult lymph node cells were labeled with an
aliphatic fluorescent chromophore before injection. Fluores-
cence microscopy analysis on frozen sections showed that
3 h after injection, large numbers of adult cells had reached
the subcapsular sinus of the lymph node and had colonized
the body of the node at 24 h (data not shown).
As BALB.D2 B lymphocytes express the Mtv-7sAg constitut-
ively, these mice are almost completely devoid of Vβ61CD41
T cells due to clonal deletion. T cells from neonatal BALB/c
mice receiving lymph node cells from adult BALB.D2 mice
responded maximally in the peripheral draining lymph node
independently of the age of the recipient (Fig. 2). The reduced
response in 30-day-old mice receiving BALB.D2 lymph node
cells was not seen in other experiments. To ensure that
neonatal T cells can respond to sAg in the absence of adult
T cells, we depleted donor BALB.D2 T cells prior to transfer.
The sAg response remained unchanged (data not shown).
To test whether neonatal B cells also have the ability to
induce a sAg response in neonatal BALB/c mice, Mtv-7-
congenic B cells from lymph node of 12- to 18-day-old mice
or as a control B cells from adult mice were injected into
Table 1. Adult and 12-day-old BALB/c mice were injected
with lymph node cells from 12-day-old, 18-day-old or adult
Mtv-7 expressing BALB.D2 mice
Age of donor Recipient Percent s.f.c./106 cells
BALB.D2 mice BALB/c Vβ61CD41 IgG
(days) T cells
– 90 13.7 0
90 90 36.7 6080
18 90 28.2 280
12 90 38.1 170
– 12 13.6 0
90 12 31.2 7200
18 12 26.9 320
Lymph node cells corresponding to 93105 B cells were injected.
Uninjected mice were used as controls. The sAg-induced T cell
response (by FACS analysis) and the antibody secretion patterns (by
ELISPOT assay) were measured 6 days after footpad injection. Each
value represents an experiment with a pool of three to four mice. The
experiment was performed 4 times. Antibody secretion by B cells
was always very low when B cells from young mice were injected
and was high when B cells from adult mice were injected. In three
out of four experiments we obtained T cell stimulations as shown in
the table, whereas in the fourth, the increase in Vβ6 T cells was
weaker in newborn mice than in adult mice.
mice of different ages. A clear and strong activation was
reproducibly seen in all combinations (Table 1). Injection of
splenocytes instead of lymph node cells from young BALB.D2
mice (12–18 days) induced only a weak sAg response (data
not shown, see Discussion).
These results indicate that neonatal T cells are sufficiently
mature to mount a strong sAg response.
Antibody secretion after adoptive transfer of Mtv-7 sAg-
expressing B cells
Having shown that neonatal T cells respond to sAg, we asked
whether these T cells could help B cells to differentiate into
antibody-secreting cells. To answer this question, Mtv-7-
congenic B cells from lymph nodes of 12-, 18- or 90-day-old
mice were injected into neonatal or adult BALB/c mice. Six
days after footpad injection, popliteal lymph nodes were
removed and the number of antibody-secreting B cells quanti-
fied by ELISPOT assay (Table 1). Despite the comparable
T cell response in all combinations, strong antibody secretion
was only observed when B cells from adult BALB.D2 mice
were injected into neonatal or adult mice. Injection of B cells
from neonatal mice did not lead to strong antibody secretion
even in adult recipients. To see whether the B cell response
was delayed in neonatal mice, we analyzed antibody secretion
10 days after injection of neonatal BALB.D2 B cells into
neonatal or adult BALB/c recipients. No antibody response
was detectable in ELISPOT assays (data not shown).
To determine the Ig isotypes induced by the sAg response,
we used four groups of mice of different ages. Two groups
were injected with BALB.D2 lymphocytes from adult or neo-
natal (day 10) mice. The third was injected with MMTV(SW)-
infected milk and the fourth remained unimmunized. When
neonates or adult mice were injected with lymph node cells
from adult BALB.D2 mice, a strong IgG response was found.
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Fig. 3. Kinetics of Ig IgG isotype secretion after MMTV(SW) or
Mtv-7 cell injection. At different ages after birth, BALB/c mice were
injected into the footpad with adult Mtv-7 BALB.D2 cells (33106) (A)
or MMTV(SW)-infected milk (B). The results for total lymph node cells
were similar to T cell depleted lymph node cells. Six days post-
injection, cells from the draining popliteal lymph node were isolated
and the number of B cells secreting different isotypes (s.f.c.) was
assessed by ELISPOT assay. Injection of neonatal Mtv-7 congenic
lymphocytes induced no significant Ig secretion (data not shown).
Each point represents the mean of three to six mice and each
experiment was repeated 3 times with similar results. In (B) day
6–17 are the results from mice injected at 6, 8, 15 or 17 days which
all were negative.
The numbers of IgG2a-secreting cells were predominant
(Fig. 3A). This initial IgG response was reduced between the
ages of 17 and 34 days, and the response in neonatal mice
was always stronger than that in adult mice. The transfer of
T cell-depleted BALB.D2 lymphocytes from adult mice
showed a similar antibody response. Therefore we concluded
that by the age of 6 days, neonatal T cells are mature
enough to help to establish a sAg-induced antibody response,
provided efficient antigen presentation occurs.
Injection with infectious MMTV(SW) does not lead to a
significant sAg response before 10 days of birth (Fig. 2). The
absence of T cell stimulation following MMTV(SW)-injection
prior to 10 days of age is due to a lower level of infection of
sAg-presenting cells (data not shown). Between day 20–25,
however, sAg-induced T cell stimulation was comparable
(Fig. 2 and data not shown). Neonates injected with
MMTV(SW)-infected milk did not show a humoral immune
response before 20 days of age (Fig. 3B). From 20 to 22
days only a few IgM- and IgG-secreting cells were detected.
Thereafter, on days 23, 24 and 26 the number of antibody-
secreting cells reached levels comparable to those observed
in adult mice, and were mainly of IgG2a isotype. These results
show that despite normal T cell responses, B cells from 20-
to 22-day-old mice are not induced to secrete antibodies
after MMTV injection.
We also analyzed the antibody-secretory capacity of the
neonatal Peyer’s patches which, as established previously,
develop a sAg-dependent T cell response to MMTV shortly
after birth (33). Peyer’s patches chronically infected by the
oral route in BALB/c neonates showed a full capacity to
secrete IgA and IgG isotypes within 9 days of birth (data
not shown).
Discussion
In this study we investigated the reduced immune response
of neonatal mice. Using vaccinia virus infection and adjuvant-
antigen injections we confirmed earlier observations indicating
that neonatal mice were able to mount a strong immune
response after viral infection but showed reduced antibody
responses after antigen application. Taking advantage of
endogenous sAg expressed by B cells we were able to show
that this reduced immune response of the neonate was due
to an immaturity of the B cell in vivo. Neonatal T cells as well
as the environment of the neonatal lymph node were not
responsible for this reduced responsiveness.
The capacity of mice to induce a specific antibody response
to T-dependent antigens develops gradually during the neo-
natal period. At this early stage of life, the development of
the immune response depends on the type of antigen, adjuv-
ant and the mouse strain used (3,4,34). A strong increase in
the number of B and T cells bearing antigen receptors is
observed in peripheral lymph nodes during the first week of
life. Thereafter, the increase in lymphocyte number is only
minor (34,35), suggesting that the lack of antigen-specific
immune responses for most antigens in neonatal mice is
not due to the absence of specific lymphocytes in the
lymph nodes.
Several receptor–ligand pairs, either expressed by antigen-
presenting cells (CD80/86, OX-40L and CD40) or by T cells
(CD28, OX40 and CD40L), are crucial for antibody responses
(for review see 36–38). It has been argued that one reason
for the inability of neonates to mount an efficient antibody
response is the low level of CD40L expression on T cells as
this is one of the key co-stimulatory molecules responsible
for inducing B cell activation and differentiation (39 and
references therein). Here we show that neonatal T cells are
fully capable of providing help to adult B cells in vivo.
Therefore it seems unlikely that the low levels of cytokines
secreted by or of co-stimulatory molecules expressed on
neonatal T cells are responsible for the reduced antibody
production.
Neonatal B cells in contrast to those of adult mice show a
reduced proliferative response after cross-linking of surface
Ig with anti-IgM, anti-IgD dextran or anti-IgD plus IL-4
(40–42). Recent evidence suggests different signal transduc-
tion patterns in neonatal B cells after Ig cross-linking (43,44).
Utilization of Th2 clones, however, showed that neonatal
B cells were able to elicit IgG and IgM responses in vitro
(45). These results suggest that although neonatal B cells
can be stimulated to secrete antibodies and to proliferate,
they require stronger stimulation than B cells of adult mice.
Injection of vaccinia virus induced a strong T-dependent
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polyclonal antibody response early after infection. A compar-
able polyclonal IgG response was found in mice of all ages
tested. This virus is known to induce high levels of cytokines
and type I and II IFN, as well as giving efficient co-stimulation
and bystander activation (46). The strong immune stimulation
induced by vaccinia virus might be required for induction of
an IgG response in a neonatal environment where memory
T and B cells are absent. It has been shown that polyclonal
B cell activation by lipopolysaccharide can help specific
antibody production in newborn mice (35). In addition, killed
B. pertussis bacteria have been shown to induce strong IFN
production, and enhanced the neonatal and adult immune
response (47). This confirms the absence of an intrinsic defect
in the generation of a T cell-dependent antibody response
when additional stimulation is provided. Similarly utilization of
strong adjuvants allows induction of antibody responses in
neonatal mice (15).
To analyze the role of B or T cell maturity in this delayed
antibody response, we used MMTV sAg. This system offers
the following advantages: (i) the sAg is presented by B cells,
(ii) T–B cell interaction is comparable to classical antigen
systems (16), (iii) sAg-reactive T cells can be easily quantit-
ated and (iv) MMTV sAg induce a strong T-dependent poly-
clonal IgG response in the absence of adjuvants (25,26). sAg
therefore can be used as tools to determine the role of T and
B cells during an immune response in neonatal and adult
mice. A study using a similar approach suggested that
neonatal T cells respond poorly to sAg-specific T cell stimula-
tion (48). These results contradict our study and are most
likely due to the use of neonatal Mtv-congenic splenocytes
instead of lymph node cells. We also have repeatedly
observed this lack of T cell stimulation when injecting BALB.D2
splenocytes into newborn mice (data not shown). In contrast
to neonatal lymph nodes, neonatal spleen is a hematopoietic
organ and contains only a few mature B cells. In this study
we have clearly shown that neonatal T cells can respond to
Mtv-7 sAg expressed by B cells derived from adult or neonatal
mice, but only induce B cell differentiation when B cells from
adult mice were injected.
Taken together, our results show an inefficient differentiation
of neonatal B cells into antibody-secreting plasma cells after
interaction with neonatal or adult T cells. B cells are clearly
responsible for the reduced antibody production. This ineffi-
cient B cell differentiation can be due to an inability of neonatal
B cells to receive or stimulate T cell help.
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